Phase 4
N=128
Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep
Colorectal Cancer
Bottom Line
View on ClinicalTrials.gov: NCT01695863 ↗Enrolled (actual)
128
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: Bowel Prep Efficacy - Boston Bowel Preparation Scale (BBPS) — 1.79; 2.33; 2.06; 2.45 score on a scale — p=<0.0001
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- comparing 2 drugs on their effect on the bowel preparation for colonoscopy (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Rush University Medical Center
- Primary completion
- Nov 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Bowel Prep Efficacy - Boston Bowel Preparation Scale (BBPS) |
1.79; 2.33; 2.06; 2.45; 2.24; 2.46 | <0.0001 sig |
| SECONDARY Renal Function Pre and Post Bowel Prep (mg/dL) |
0.18; 0.02; 1.41; 3.44; 3.44; 3.00 | 0.093 |
| SECONDARY Renal Function Pre and Post Bowel Prep - Continued (mmol/L) |
0.27; -0.92; -0.18; -0.11; 0.54; -0.44 | — |
Summary
This study will be comparing patient satisfaction, efficacy comparing miralax with gatorade versus Movi Prep for outpatient colonoscopy.
Eligibility Criteria
Inclusion Criteria
- outpatient colonoscopy for screening for other Gi related problems
Exclusion Criteria
- Severe Congestive Heart Failure (CHF),
- Chronic Kidney Disease (CKD),
- less than age 18 or more than 80 years
Data sourced from ClinicalTrials.gov (NCT01695863). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.